BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32075951)

  • 1. Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
    Li G; Shen Y; Wang F; Hong S; Cai M
    Med Sci Monit; 2020 Feb; 26():e920473. PubMed ID: 32075951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation.
    Bucau M; Laurent-Bellue A; Poté N; Hentic O; Cros J; Mikail N; Rebours V; Ruszniewski P; Lebtahi R; Couvelard A
    Neuroendocrinology; 2018; 106(3):274-282. PubMed ID: 28803235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL.
    Zou W; Cheng J
    Technol Cancer Res Treat; 2020; 19():1533033820940425. PubMed ID: 32912113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
    Li YC; Yang CS; Zhou WL; Li HS; Han YJ; Wang QS; Wu HB
    World J Gastroenterol; 2018 Jan; 24(4):494-503. PubMed ID: 29398870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
    Zhou X; Hu Y; Sun H; Chen R; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3107-3115. PubMed ID: 37147479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
    Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
    Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructose-1,6-Bisphosphatase 1 Reduces
    Chen R; Li J; Zhou X; Liu J; Huang G
    Radiology; 2017 Sep; 284(3):844-853. PubMed ID: 28387640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of (18)F-FDG PET in preoperative TACE of hepatocellular carcinoma].
    Chang Z; Song P; Wang M; Liu F; Duan F; Wang Z; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):377-81. PubMed ID: 25030595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of ALDOB expression and
    Jia W; Wu Q; Yu X; Shen M; Zhang R; Li J; Zhao L; Huang G; Liu J
    Front Oncol; 2022; 12():1044902. PubMed ID: 36644641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated expression of VHL mRNA variants in papillary thyroid cancer.
    Baldini E; Tuccilli C; Arlot-Bonnemains Y; Chesnel F; Sorrenti S; De Vito C; Catania A; D'Armiento E; Antonelli A; Fallahi P; Watutantrige-Fernando S; Tartaglia F; Barollo S; Mian C; Bononi M; Arceri S; Mascagni D; Vergine M; Pironi D; Monti M; Filippini A; Ulisse S
    Mol Cell Endocrinol; 2017 Mar; 443():121-127. PubMed ID: 28089820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
    Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
    Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of
    Wu B; Zhang Y; Tan H; Shi H
    Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.